<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Solanesyl Diphosphate Synthase, Enzyme Ubiquinone <br /> Synthetic Pathway, Is Required Life Cycle of <br /> Trypanosoma brucei <br /> De-Hua Lai,a,b* Estefan&#195;&#173;a Poropat,c Carlos Pravia,c Malena Landoni,d Alicia S. Couto,d Fernando G. P&#195;&#169;rez Rojo,e Alicia G. Fuchs,c,e <br /> Marta Dubin,f Igal Elingold,f Juan B. Rodr&#195;&#173;guez,g Marcela Ferella,h M&#195;&#179;nica I. Esteva,c Esteban J. Bontempi,a,c Julius Luke&#197;&#161;a,b <br /> Biology Centre, Institute Parasitology, Academy Sciences Czech Republic,a Faculty Sciences, University South Bohemia,b C&#203;&#8225;esk&#195;&#169; Bude&#203;&#8225;jovice, Czech <br /> Republic; Instituto Nacional Parasitolog&#195;&#173;a Dr. M. Fatala Chab&#195;&#169;n, Ministerio Salud, Buenos Aires, Argentinac; CIHIDECAR, Departamento Qu&#195;&#173;mica Org&#195;&#161;nica, <br /> Facultad Ciencias Exactas y Naturales, Universidad Buenos Aires, Buenos Aires, Argentinad; CAECIHS, Universidad Abierta Interamericana, Buenos Aires, Argentinae; <br /> CEFYBO, UBA-CONICET, Facultad Medicina, Buenos Aires, Argentinaf; Departamento Qu&#195;&#173;mica Org&#195;&#161;nica UMYMFOR, Facultad Ciencias Exactas y Naturales, <br /> Universidad Buenos Aires, Buenos Aires, Argentinag; Department Immunology, Genetics Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Swedenh <br />  <br /> Ubiquinone 9 (UQ9), expected product long-chain solanesyl diphosphate synthase Trypanosoma brucei (TbSPPS), <br /> has central role reoxidation reducing equivalents mitochondrion T. brucei. The ablation TbSPPS gene expres- <br /> sion <span id='am-240' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-241' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-242' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-243' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-244' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-245' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-246' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-247' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-248' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-249' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-250' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-251' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-252' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-253' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-254' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-255' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-256' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-257' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-258' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-259' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-260' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-261' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-262' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-263' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-264' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-265' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-266' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-267' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-268' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-269' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-270' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-271' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-272' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-273' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-274' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-275' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-276' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-277' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-278' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-279' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-280' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-281' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-282' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-283' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-284' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-285' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-286' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-287' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-288' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-289' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-290' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-291' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-292' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-293' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-294' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-295' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-296' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-297' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-298' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-299' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-300' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-301' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-302' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-303' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-304' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-305' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-306' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-307' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-308' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-309' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-310' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-311' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-312' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-313' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-314' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-315' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-316' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-317' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span>RNA interference</span> increased generation reactive oxygen species reduced cell growth oxygen consumption. <br /> The addition glycerol culture medium exacerbated <span id='am-84' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-85' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-86' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-87' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-90' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-91' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-92' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-93' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-94' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-96' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-100' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-103' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-104' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-105' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-106' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-107' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-108' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-109' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-110' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-111' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-113' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-114' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-116' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-117' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-119' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-120' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-125' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-131' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-133' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-134' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-135' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-139' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-143' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-144' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-147' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-151' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-152' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-154' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-157' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-158' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-159' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-160' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-161' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span>phenotype</span> blocking endogenous generation excretion. <br /> The participation TbSPPS UQ synthesis confirmed growth rescue using UQ 10 isoprenyl subunits <br /> (UQ10). Furthermore, <span id='am-6' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-7' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-8' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-9' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-11' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-13' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-17' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-21' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-23' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-25' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-26' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-30' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-32' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-34' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-38' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-40' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-41' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-55' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-58' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-60' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-61' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-62' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-63' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-65' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-67' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-68' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-69' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-70' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-71' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-73' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-74' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-82' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-83' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span>survival</span> infected mice prolonged downregulation TbSPPS and/or addition of <br /> glycerol drinking water. TbSPPS inhibited 1-[(n-oct-1-ylamino)ethyl] 1,1-bisphosphonic acid, treatment this <br /> compound lethal cells. The findings UQ9 ATP pools severely depleted drug exoge- <br /> nous UQ10 able fully rescue growth inhibited parasites strongly suggest TbSPPS UQ synthesis the <br /> main targets drug. These strategies highlight importance TbSPPS T. brucei, justifying efforts vali- <br /> date new drug target. <br />  <br />  <br />  <br />  <br /> T   hemoflagellate parasite Trypanosoma brucei responsible <br />     sleeping sickness, disease affecting humans and <br /> other vertebrates sub-Saharan Africa. The main drugs used for <br />                                                                                       far UQ9 detected BSF T. brucei mevalonate, <br />                                                                                       labeled precursor (16, 17). <br />                                                                                           Due importance UQ parasite&#226;&#8364;&#8482;s metabolism, we <br /> treatment numerous effects, complicated                         decided study TbSPPS (the T. brucei solanesyl diphosphate syn- <br /> administer, poor efficiency increasing incidence drug                     thase), responsible synthesis 9 isoprenyl subunit <br /> resistance reported (1). Therefore, new drugs targeting                      chains. Alterations UQ level affect oxygen consump- <br /> essential metabolic pathways urgently needed.                                     tion, reoxidation NADH, ATP pool. Indirectly, the <br />     We interested polyprenyl diphosphate synthases, en-                        mitochondrial membrane potential PCF, produced via <br /> zymes catalyze elongation isoprenoid chains                       respiratory chain aerobic eukaryotes, could <br /> the condensation isopentenyl pyrophosphate (a 5-carbon <span id='am-1' about='Thesaurus:Unit' typeof='owl:Thing'>unit</span>,                       decrease. The situation different mammalian-infective <br /> C5) allylic prenyl pyrophosphates (2) produce chains                       BSF cells, uniquely generate potential the <br /> variable <span id='am-4' about='xsp:length' typeof='owl:Thing'>length</span>. The detection prenylated proteins showed                     ATP-consuming reverse action ATP synthase (18). Since UQ <br /> short isoprenoid chains, farnesyl geranygeranyl, in-                     participates regeneration NADH required ATP <br /> deed attached proteins protist (3, 4). Activities key <br />                                                                                       synthesis glycosomes, shortage reduced cofactor is <br /> enzymes pathway T. brucei, namely, farnesyl diphos- <br />                                                                                       likely decrease ATP level compartment, in <br /> phate synthase farnesyl transferase, characterized <br />                                                                                       cytoplasm mitochondrion. <br /> (5, 6, 7). Moreover, promising inhibitors farnesyl diphosphate <br /> synthase antiparasitic activities tested vitro (8, 9, <br /> 10) vivo (11). <br />                                                                                           Received 6 October 2013 Accepted 20 December 2013 <br />     On hand, enzymes synthesizing longer isoprenoid <br />                                                                                           Published ahead print 27 December 2013 <br /> chains far thoroughly studied trypanosoma- <br />                                                                                           Address correspondence Esteban Bontempi, ejbon@yahoo.com, or <br /> tids (9, 12). Their product likely incorporated ubiqui- <br />                                                                                           Julius Luke&#197;&#161;, jula@paru.cas.cz. <br /> none (UQ), central role respiration T. brucei                       * Present address: De-Hua Lai, Center Parasitic Organisms, State Key Laboratory <br /> has well-studied metabolically distinct stages life cycle.                     Biocontrol, School Life Sciences, Sun Yat-Sen University, Guangzhou, <br /> The bloodstream form (BSF), present vertebrate blood, respires                         People&#226;&#8364;&#8482;s Republic China. <br /> solely trypanosome alternative oxidase (TAO), pro-                          Supplemental material article http://dx.doi.org/10.1128 <br /> cyclic form (PCF), occurs tse-tse fly vector, uses                      /EC.00271-13. <br /> TAO cytochrome c- containing respiratory chain enzymes                                Copyright &#194;&#169; 2014, American Society Microbiology. All Rights Reserved. <br /> (for reviews, references 13 14). Although UQs different                        doi:10.1128/EC.00271-13 <br /> lengths various parasitic protists (12, 15), so <br />  <br />  <br /> 320   ec.asm.org                                          Eukaryotic Cell   p. 320 &#226;&#8364;&#8220;328                                              February 2014 Volume 13 Number 2 <br />                                                                                                                       T. brucei Solanesyl Diphosphate Synthase <br />  <br />  <br />  <br />     Reactive oxygen species (ROS) generated low                 constructs selected described (32, 33). The PCF flagel- <br /> rate by-product respiratory chain, mainly com-                 lates cultured 27&#194;&#176;C SDM79 medium supplied 15 &#226;?&#174;g ml&#226;&#171;&#186;1 <br /> plexes I III (19, 20). Having central position respira-            neomycin G418 50 &#226;?&#174;g ml&#226;&#171;&#186;1 hygromycin diluted 106 cells ml&#226;&#171;&#186;1 <br /> tory chain, UQ receives typical cell electrons complexes              day, BSF kept 37&#194;&#176;C HMI-11 medium 2.5 <br /> I II and, present, alternative NADH dehydrogenase.                  &#226;?&#174;g ml&#226;&#171;&#186;1 G418 5% CO2 diluted 105 cells ml&#226;&#171;&#186;1 day. <br /> While presence activity T. brucei PCF com-               Phleomycin-resistant transfectants stages (2.5 1.3 &#226;?&#174;g ml&#226;&#171;&#186;1) <br /> plex II rotenone-insensitive alternative NADH dehydroge-                    cloned limiting dilution, RNAi induced adding 1 &#226;?&#174;g <br />                                                                                 ml&#226;&#171;&#186;1 tetracycline medium. Lister 427 PCF (29-13) BSF (90-13) <br /> nase undisputed (13, 14, 21, 22), composition (23, 24) <br />                                                                                 cell lines (34) used inhibition experiments. Cell concentra- <br /> and activity complex I highly unusual (25, 26). <br />                                                                                 tions determined using Neubauer hemocytometer Z2 <br /> Diminishing cellular concentration UQ favor                Coulter Counter. <br /> increase reduced NADH pool parallel formation                         Northern Western blot analyses. Total RNA isolated using <br /> ubisemiquinone, facilitating deviation electrons oxygen               TRIzol (Sigma), 10 &#226;?&#174;g RNA lane loaded 1% formal- <br /> with consequent mitochondrial ROS formation. A lower                     dehyde agarose gel, blotted, linked membrane, hybridized with <br /> of UQ affect function membranes outside                   radiolabeled probe conditions described (35). Total cell <br /> mitochondrion, reduces lipid peroxyl radicals radical              lysates separated 12% SDS-PAGE gels, transferred membranes, <br /> scavengers like &#226;?&#163;-tocopheryl and, cytochrome b5               probed polyclonal antibodies RNA binding protein 16 <br /> reductase, gene present T. brucei genome,                  (RBP16; kindly provided L. Read) TbSPPS 1:1,000 dilu- <br /> assists extracellular ascorbate stabilization (27). Hence, de-           tions (28). Appropriate secondary antibodies (1:2,000; Sevapharma, <br /> pletion UQ pool T. brucei disrupt redox equilib-              Czech Republic) coupled horseradish peroxidase visualized using <br /> rium, increasing ROS multifaceted action.                             enhanced chemiluminescence kit (Pierce) according manufac- <br />     Indeed, downregulation mitochondrion-confined                    turer&#226;&#8364;&#8482;s protocol. <br /> TbSPPS (28) triggered metabolic effects life stages               Measurement respiration rate, &#226;&#338;&#172;&#226;&#338;&#191;m, reactive oxygen spe- <br />                                                                                 cies. Oxygen consumption stages measured described else- <br /> T. brucei. These effects mimicked wild-type cells the <br />                                                                                 (35, 36). Changes ROS mitochondrial membrane poten- <br /> TbSPPS bisphosphonate inhibitor 1-[(n-oct-1-ylamino)ethyl]                      tial (&#226;&#338;&#172;&#226;&#338;&#191;m) determined using FACSCalibur FACSAria flow <br /> 1,1-bisphosphonic acid (compound 1) (9). In vivo, infected mice                 cytometer instruments (Becton, Dickinson) addition dihydro- <br /> displayed longer survival TbSPPS ablated RNA in-                    ethidium, TMRE, Mitotracker Deep Red cell suspensions (106 <br /> terferenec (RNAi), confirming importance metabolism                  cells ml&#226;&#171;&#186;1) final concentrations 15 &#226;?&#174;M, 250 nM, 500 nM, respec- <br /> of parasite.                                                                tively, carbonyl cyanide m-chlorophenyl hydrazine (CCCP) final <br />                                                                                 concentration 20 &#226;?&#174;M used control. A total 10,000 events were <br /> MATERIALS AND METHODS                                                           acquired region previously established corresponding the <br /> Materials. Compound 1 prepared previously described (9). Nickel-         parasites. Data analyzed one-way analysis variance <br /> nitrilotriacetic acid-agarose obtained Qiagen, paraquat, di-       (ANOVA). Significant differences means identified Tukey <br /> hydroethidium, UQ10 provided Sigma. UQ10/&#226;?&#164;-cyclodex-                Dunnett posttests, P value &#226;&#177;&#8226;0.05 adopted mini- <br /> trin (a kind gift A. &#197;&#160;midovnik) complex 7.5% UQ10 (Bulk            mum criterion significance. Statistical analyses performed using <br /> Medicines &amp; Pharma, Germany) &#226;?&#164;-cyclodextrin (Xi&#226;&#8364;&#8482;an HongChang                GraphPad software. Alterations fluorescence quantified as <br /> Pharma, China). Tetramethylrhodamine ethyl ester (TMRE) pur-                percentage variation compared untreated parasites used as <br /> chased Molecular Probes, Mitotracker Deep Red CellTiter-           control. The data shown graphs figures expressed as <br /> Glo reagent obtained Invitrogen Promega, respectively.            means &#226;&#171;&#190; standard deviations independent experiments. <br />     DNA sequencing bioinformatics. The entire coding sequence                 In vivo infectivity glycerol treatment. Mice food fresh <br /> the TbSPPS gene PCR amplified genomic DNA (strain 29-13)               water available ad libitum. The housing conditions, care, handling, and <br /> using primers PreBru1 (5=-CCTCGAGATCTATGCACCGTGCTAAT                        euthanasia method approved institution&#226;&#8364;&#8482;s Animal Ethics <br /> ATTATAT-3=) PreBru2 (5=-CCAAGCTTCACAATTCCCGTGTCA                            Committee. <span id='am-5' about='protege:TO' typeof='owl:Thing'>To</span> determine infectivity trypanosomes depleted for <br /> GG-3=), introduced BglII HindIII restriction sites, respectively, <br />                                                                                 TbSPPS, groups CD-1 mice (5 animals each) infected intra- <br /> for convenient cloning p2T7-177 RNAi expression vectors. In <br />                                                                                 peritoneally 100,000 BSF RNAi cells. In drinking water, first <br /> addition, primer PreBru1 contains XhoI restriction site, was <br />                                                                                 group received 1 mg ml&#226;&#171;&#186;1 doxycycline (AppiChem) sweetened 50 <br /> used cloning pZJM RNAi vector. All constructs verified <br />                                                                                 mg ml&#226;&#171;&#186;1 sucrose, starting 2 days infection. The second group <br /> by sequencing. Homology searches performed using BLAST or <br />                                                                                 received 5% glycerol drinking water, group received <br /> GeneDB, sequences aligned using ClustalX 1.81. The molecular <br /> weight isoelectric point obtained ExPASy server (cn-          glycerol doxycycline. The control group supplied pure <br /> .expasy.org).                                                                   drinking water. The survival recorded twice day. <br />     Determination EC50s. Parasites adjusted initial concen-            High-performance liquid chromatography. To calibrate high- <br /> tration 5 &#226;&#171;&#187; 104 BSF 1 &#226;&#171;&#187; 106 PCF ml&#226;&#171;&#186;1 200 &#226;?&#174;l medium loaded          performance liquid chromatography (HPLC) column, following mol- <br /> into sterile 96-well plates. Two-fold serial dilutions compound 1            ecules run: UQ8 extracted hexane Escherichia coli, UQ9 <br /> (boiled ensure complete dissolution sterility) added dupli-      isolated T. brucei, commercially available UQ10. Treated (1 &#226;?&#174;M <br /> cate wells. After 3 days, cells wells counted using Neubauer   compound 1) untreated BSF pelleted diluted 1 ml meth- <br /> hemocytometer. Each assay repeated times. The EC50 (effective         anol. As internal standard, known UQ10 added. The <br /> concentration half-maximal growth inhibition) determined using          samples extracted twice 1 ml hexane. Both extraction fractions <br /> the CompuSyn software (Combosyn) (29).                                          pooled, dried nitrogen flow, dissolved hexane. Samples <br />     Plasmid constructs, transfections, cloning, RNAi induction,             analyzed HPLC Waters apparatus Supelco C18 column at <br /> cultivation. The full-size TbSPPS gene (1,080 bp) cloned           0.7 ml min&#226;&#171;&#186;1 flow. The mobile phase methanol:hexane, 80:20 (vol/ <br /> pZJM (30) p2T7-177 (31) vectors using XhoI, BglII,               vol), isocratic, loop 5 &#226;?&#174;l, detection 275 nm. All <br /> HindIII sites included primer sequences. T. brucei PCF 29-13         solvents HPLC grade. The UQ9 quantified the <br /> BSF single marker (SM) cell lines transfected linearized          area curve comparison UQ10 standard. <br />  <br />  <br /> February 2014 Volume 13 Number 2                                                                                                             ec.asm.org 321 <br />  Lai et al. <br />  <br />  <br />  <br />     Measurement ATP content. An equal volume CellTiter-Glo <br /> reagent (Promega) added T. brucei, 10-min incubation, <br /> luminescence read Glomax multidetection (Promega). <br /> The signal directly related (r2 &#226;&#171;&#189; 0.99) cell number well, in <br /> the range 30,000 500,000 cells. The luminescence produced se- <br /> rum-supplemented HMI-11 medium 2 orders magnitude <br /> lower produced flagellates. <br />  <br /> RESULTS <br /> TbSPPS gene. The Trypanosoma cruzi TcSPPS gene, used a <br /> query, identified single T. brucei gene (Tb09.160.4300), which <br /> encodes protein calculated molecular mass 39.2 kDa <br /> and isoelectric point 6.12. The alignment TbSPPS and <br /> TcSPPS revealed proteins presence seven regions <br /> related catalysis binding (37, 38) (see Fig. S1 supple- <br /> mental material). The TbSPPS gene, identical strains 29-13 and <br /> TREU927/4, highly conserved T. brucei T. cruzi, as <br /> there 66% 68% identity (83% similarity) nucleotide <br /> and amino acid levels, respectively (see Fig. S1). Additionally, al- <br /> anine occupies position &#226;&#171;&#186;5 second aspartate- <br /> rich motif (see Fig. S1), allowing elongation isoprenoid               FIG 1 Northern Western blot analyses TbSPPS T. brucei RNAi cell <br /> chain longer C15 (39).                                                   lines. (A) Effects TbSPPS RNAi mRNA protein levels procyclic <br />     Inhibition TbSPPS expression RNAi. To assess im-                stage (clone 4). Total RNA protein extracted parental 29-13 <br /> portance protein parasite&#226;&#8364;&#8482;s metabolism, PCF                cells (lane 1), noninduced cells (lane 2), procyclic cells day 6 RNAi <br />                                                                               induction (lane 3). The upper panels Northern blot analysis results <br /> BSF cells transfected pZJM p2T7-177 RNAi <br />                                                                               full-length TbSPPS gene used probe. Ethidium bromide-stained <br /> vectors, respectively, bore full-length TbSPPS                rRNAs used loading control. The lower panels Western blot <br /> gene. First, total RNA isolated noninduced                   analysis results showing expression TbSPPS protein cell lines <br /> RNAi-induced PCF clonal cell line analyzed Northern                    RNA panels. The target protein detected specific polyclonal <br /> blotting. In parental 29-13 cells, TbSPPS abundantly tran-            anti-TbSPPS antibodies. Antibody RBP16 used loading con- <br />                                                                               trol. (B) Effects TbSPPS RNAi mRNA protein levels blood- <br /> scribed (band &#226;&#172;&#402;1.9 kb) (Fig. 1A; Fig. S1 supple-           stream stage (clone 6) day 3 RNAi induction. Total protein ex- <br /> mental material), but, probably small leakage              tracted parental SM cells (lane 1), noninduced cells (lane 2), and <br /> of T7 promoter, TbSPPS mRNA present non-                  bloodstream cells 3 days RNAi induction (lane 3). TbSPPS RBP16 <br /> induced cells (clone 4). This effect likely reflected         detected described panel A. <br /> slight growth inhibition noninduced cells compared the <br /> 29-13 parental cells (Fig. 2A). Upon induction RNAi tet- <br /> racycline, TbSPPS mRNA undetectable 2 days,              chrome c oxidase (complex IV) TAO, respectively, used <br /> concurrent massive appearance double-stranded RNA (Fig.                    discriminate oxygen consumption path- <br /> 1A), slow growth phenotype PCF started day 7               way. Upon RNAi induction, switch pathway the <br /> (Fig. 2A). Based growth curve, day 6 post-RNAi induction               observed, indicating decreased oxygen con- <br /> was selected subsequent experiments. At time point,          sumption rate caused (Fig. 3A; Fig. <br /> levels TbSPPS mRNA corresponding protein                    S3A E supplemental material). On hand, the <br /> undetectable Northern Western blot analyses (Fig. 1A),                 oxygen consumption BSF, rely solely TAO, dropped <br /> confirming high efficiency RNAi.                                       day 3 post-RNAi induction 50%, compared parental <br />     The viability BSF cells compromised RNAi             noninduced parasites (Fig. 3B; Fig. S3F). <br /> induction. As revealed Western blot analysis, TbSPPS                      Inhibition BSF RNAi cells glycerol compound 1. Un- <br /> equally abundant parental SM noninduced cells                  der hypoxic anaerobic conditions, glycerol-3-phosphate and <br /> (clone 6), protein downregulated day 3               ADP accumulate glycosomes, causing glycerol ki- <br /> post-induction (Fig. 1B). As judged the protein,             nase operate reverse excrete glycerol (40). Under these <br /> there leakage. Although disappearance                  conditions, exogenous glycerol added medium a <br /> TbSPPS RNAi induction complete, growth inhibi-                   toxic metabolite, diffuse cells, inhibiting the <br /> tion started day 2 (Fig. 2B).                                      glycerol kinase activity preventing NAD&#226;&#171;&#185; regeneration (41). <br />     Diminished O2 consumption. As shown Fig. 3, respiration                Since ablation TbSPPS RNAi decrease function of <br /> of noninduced PCF cells represented 90%              glycerol-3-phosphate shuttle, addition glycerol should <br /> parental cell line remained the days            enhance ensuing phenotype. Indeed, addi- <br /> after RNAi induction. However, day 6, oxygen consump-                  tion 4 mM glycerol HMI-11 medium 5 days had <br /> tion rate RNAi-induced cells dropped approximately                  just mild inhibitory effect parental BSF cells (3.4 times <br /> 60%, correlation appearance growth phenotype.              slower growth) noninduced TbSPPS BSF cells (5.2 times <br /> The diminished O2 consumption lasted till day 10 postinduc-              slower growth), RNAi-induced counterparts effect <br /> tion, measurement finished (Fig. 3). Cyanide (KCN)               dramatic (48.7 times slower growth) (Fig. 4A). <br /> and salicylhydroxamic acid (SHAM), inhibitors cyto-                       Next, examined effect 1-[(n-oct-1-ylamino)ethyl] <br />  <br />  <br /> 322    ec.asm.org                                                                                                                                Eukaryotic Cell <br />                                                                                                                            T. brucei Solanesyl Diphosphate Synthase <br />  <br />  <br />  <br />  <br /> FIG 2 Effects TbSPPS RNAi cell growth procyclic form (A)         FIG 3 Effects TbSPPS RNAi oxygen consumption rate pro- <br /> bloodstream form (B) T. brucei. Cell densities (in cells ml&#226;&#171;&#186;1) procyclic <br />                                                                                   cyclic (A) bloodstream (B) forms cells. (A) For procyclics, relative <br /> forms bloodstream forms measured diluted described the <br />                                                                                   contributions alternative pathway TAO cytochrome- <br /> text. The total cell numbers calculated plotted logarithmic scale <br />                                                                                   mediated pathway (OXPHOS) measured parental 29-13 cells, nonin- <br /> on y axis 14 days (A) 6 days (B). Clonal procyclic form (A) and <br />                                                                                   duced cells (-), cells 2, 6, 10 days RNAi induction. The amount <br /> bloodstream form (B) parasite growth absence presence 1 mg ml&#226;&#171;&#186;1 <br />                                                                                   O2 consumption inhibited KCN (0.1 mM) reflected capacity the <br /> tetracycline, induces RNAi, indicated graphs. The growth data <br />                                                                                   cytochrome-mediated pathway, inhibited SHAM (0.03 <br /> for parental procyclic (strain 29-13 [A]) bloodstream (SM [B]) forms are <br />                                                                                   mM) represented TAO activity. The noninhibited residual oxygen con- <br /> also shown. <br />                                                                                   sumption taken zero. The means standard deviation values three <br />                                                                                   experiments shown. (B) In absence cytochrome-mediated path- <br />                                                                                   way bloodstream-form cells, respiration mediated TAO. Oxygen <br />                                                                                   consumption measured parental SM cells, noninduced cells (-), cells <br /> 1,1-bisphosphonic acid, termed compound 1,                        1 3 days RNAi induction, cells inhibition compound 1 (1 &#226;?&#174;M <br /> TbSPPS bisphosphonate inhibitor (Fig. 4B). After addition                  24 h), RNAi cell group supplied UQ10. Statistical significance <br /> compound 1 (1 &#226;?&#174;M), BSF cell (SM) oxygen consumption                               levels compared control group indicated asterisks: *, P &#226;&#172;? 0.05; ***, <br /> dropped 24 h 30% nontreated parasites                    P &#226;&#172;? 0.0005; ****, P &#226;&#172;? 0.00005. <br /> (Fig. 3B; Fig. S3F supplemental material), with- <br /> out causing severe growth defect (Fig. 4C). When tested the <br /> RNAi-induced cells, strong growth inhibition occurred                      cell forms suggested dramatic increase ROS the <br /> presence concentration (lower EC50 [see be-                  PCF flagellates likely generated disruption respi- <br /> low]). Cells grew normally 2 days died suddenly              ratory chain, active life cycle stage. <br /> day 3 (Fig. 4C). It noted effect                     To corroborate result, paraquat, reagent catalyzing ROS <br /> mimicked treating parental BSF simultaneous                  formation (42), added concentrations ranging 0.5 2 <br /> addition compound 1 4 mM glycerol (22.9-fold growth                        &#226;?&#174;M noninduced RNAi-induced PCF day 5. Twenty- <br /> inhibition), suggesting minimal active en-                   hours later, increment ROS production lasted sev- <br /> zyme sufficient support growth.                                             eral days detected flow cytometry (data shown). The <br />     Measurement ROS, mitochondrial membrane potential,                         effect paralleled significant growth inhibition day 8 <br /> and effects paraquat treatment. Mitotracker TMRE                       observed paraquat-treated RNAi-induced cells compared to <br /> fluorophores sensitive mitochondrial membrane potential                    equally treated noninduced counterparts (Fig. 5B). Thus, the <br /> (&#226;&#338;&#172;&#226;&#338;&#191;m) stain functional mitochondria. Flagellates                   ROS boost knockdown cells responsible increased <br /> stages depleted TbSPPS did significant variation                 sensitivity paraquat. <br /> of potential compared parental cells.                                      Rescue RNAi exogenous UQ vivo infections. <br />     To follow possible outcome disruption                   Addition UQ, downstream product SPPS, medium <br /> respiratory system, measured generation ROS using                    alleviate effect RNAi-mediated depletion TbSPPS. <br /> dihydroethidium. Indeed, PCF cells, ROS increased contin-                  To increase hydrophilicity bioavailability, UQ usually <br /> uously, reaching maximum days 6 8 (Fig. 5A).                        provided bound compounds. We used complex of <br /> RNAi-induced BSF did change fluorescence                     UQ10 &#226;?&#164;-cyclodextrin, molecule widely used phar- <br /> addition dihydroethidium, suggesting changes ROS gen-                    maceutical industry encapsulation (43). Cells ablated for <br /> eration (data shown). The different phenotypes                    TbSPPS subjected different concentrations (1, 10, <br />  <br />  <br /> February 2014 Volume 13 Number 2                                                                                                                   ec.asm.org 323 <br />  Lai et al. <br />  <br />  <br />  <br />  <br />                                                                                      FIG 5 Generation reactive oxygen species (A) paraquat treatment (B) <br />                                                                                      TbSPPS procyclic cells. Experiments performed twice with <br />                                                                                      triplicate samples. (A) Parental 29-13 cells (area black line), noninduced <br />                                                                                      cells (gray area), procyclics 6 days RNAi induction (area gray <br />                                                                                      line) incubated presence 5 mg ml&#226;&#171;&#186;1 dihydroethidium 30 min. <br />                                                                                      The fluorescence distributions, measured flow cytometry, plotted as <br />                                                                                      frequency histograms. (B) Growth procyclic form noninduced cells (clone <br /> FIG 4 Growth curve bloodstream transfectant cells presence glyc-        4) cells induced RNAi 5 days (clone 4 Ind), incubated 3 additional <br /> erol compound 1. (A) The addition 4 mM glycerol medium           days presence 0.2, 0.5, 1, 2 &#226;?&#174;M paraquat. The growth cells the <br /> inhibitory effect TbSPPS knockdown RNAi induction (&#226;&#171;&#185;, glycerol),            absence paraquat, noninduced RNAi induced, considered to <br /> while mild effect observed SM parental cells (SM, glycerol)   100%. Statistical significance levels comparisons two <br /> noninduced cells (-, glycerol). The cell lines grown absence     groups indicated asterisks: ***, P &#226;&#172;? 0.0005; ****, P &#226;&#172;? 0.00005. <br /> glycerol controls. (B) Chemical structure 1-[(n-oct-1-ylamino)ethyl] 1,1- <br /> bisphosphonic acid (compound 1), potent inhibitor enzymatic activity <br /> of TcSPPS. (C) The addition 1 &#226;?&#174;M compound 1 medium lethal <br /> for RNAi-induced TbSPPS knockdown cells (&#226;&#171;&#185;, Comp1), just            protective effect ascofuranone (45). Four groups mice, <br /> small effect observed SM parental cells (SM, Comp1) the <br /> noninduced cells (-, Comp1). The cell lines grown absence        composed animals, infected dose <br /> compound 1 controls. The experiment repeated times,               100,000 BSF RNAi transfectants treated different sub- <br /> representative curve shown.                                                       stances, survival rate recorded. Two replications <br />                                                                                      experimental setup similar results, one <br />                                                                                      shown (Fig. 6). While 4 days average survival of <br /> and 90 &#226;?&#174;M) above-mentioned compound added                              animals control group supplied plain drinking water, <br /> cultivation medium. The growth parental cells (SM) con-                       survival rate increased significantly 7 7.6 days mice <br /> sidered 100%. In noninduced BSF cells, effect                    drinking water containing glycerol doxycycline, respectively. <br /> of concentrations growth (89 95% growth). While                          Moreover, longest average survival 11.2 days recorded <br /> RNAi-induced parasites (56% growth) marginally affected                         animals supplied drinking water containing sub- <br /> upon addition 1 &#226;?&#174;M UQ&#226;&#8364;&#8220;&#226;?&#164;-cyclodextrin (65% growth),                          stances (Fig. 6). <br /> significant rescue (79% 85% growth) observed                              Metabolic effects compound 1 T. brucei. Compound 1 <br /> presence compounds 10 &#226;?&#174;M 90 &#226;?&#174;M, respectively                         shown potent inhibitor T. cruzi SPPS, an <br /> (see Fig. S2 supplemental material). After addition                    EC50 250 nM (9). Due similarities active site the <br /> UQ10, oxygen consumption returned normal compared                          enzymatic mechanism type E-polyprenyl diphosphate syn- <br /> the parental noninduced parasites (Fig. 3B; Fig. S3F).                  thases, hypothesized compound 1 active <br />     Next, tested infection animals transfected para-                  TbSPPS protein. Indeed, affected growth of <br /> sites. In humans, ingested glycerol raise serum concentra-                   T. brucei life forms, EC50 2 &#226;?&#174;M BSF compared <br /> tion 20 mM, normal 0.05 mM level (44). In T. brucei-                     EC50 50 &#226;?&#174;M PCF. <br /> infected animals, glycerol added drinking water improved                          Since TbSPPS predicted synthesize isoprenoid chain <br />  <br />  <br /> 324    ec.asm.org                                                                                                                                      Eukaryotic Cell <br />                                                                                                                         T. brucei Solanesyl Diphosphate Synthase <br />  <br />  <br />  <br />                                                                                     bition 90-13 BSF cell line caused treatment com- <br />                                                                                     pound 1. The inhibitor used concentration 10 &#226;?&#174;M, <br />                                                                                     lethal BSF 3 days. To eliminate possibility <br />                                                                                     inhibitor getting trapped &#195;&#376;-cyclodextrin, added com- <br />                                                                                     mercial UQ10 medium. In spite limited aque- <br />                                                                                     ous solubility bisphosphonate, <span id='am-162' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-163' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-164' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-166' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-167' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-168' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-169' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-170' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-171' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-172' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-173' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-174' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-175' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-176' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-177' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-178' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-179' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-181' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-182' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-183' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-184' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-185' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-186' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-187' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-188' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-190' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-191' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-193' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-194' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-196' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-197' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-198' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-199' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-200' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-202' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-206' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-207' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-208' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-209' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-211' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-212' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-213' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-214' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-217' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-218' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-219' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-220' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-221' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-222' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-223' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-225' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-226' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-228' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-229' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-231' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-232' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-233' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-234' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-235' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-237' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-238' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-239' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span>lethal phenotype</span> was <br />                                                                                     fully superseded presence 20 &#226;?&#174;M UQ10, BSF cells <br />                                                                                     grew normal rate (Fig. 7D). <br />  <br />                                                                                     DISCUSSION <br />                                                                                     In effort novel chemotherapeutic targets patho- <br />                                                                                     genic trypanosomatids, decided study long chain poly- <br /> FIG 6 Survival mice infected TbSPPS RNAi transfectant cells was <br /> prolonged addition glycerol doxycycline. Drinking water <br />                                                                                     prenyl diphosphate synthases. Earlier, SPPS T. cruzi char- <br /> available groups mice, consisting individuals,   acterized (12), bisphosphonate inhibitors tested <br /> pure (water) supplemented 1 mg ml&#226;&#171;&#186;1 doxycyline sweetened 50            recombinant enzyme (9). In order validate <br /> mg ml&#226;&#171;&#186;1 sucrose, 5% glycerol, doxycycline glycerol. The sur-         enzymes putative targets, performed functional anal- <br /> vival mice followed daily basis.                                        ysis corresponding protein T. brucei using RNAi and <br />                                                                                     inhibition compound 1. This compound shown inhibit <br />                                                                                     SPPS farnesyl diphosphate synthase T. cruzi (9) was <br /> of UQ9, expected effect compound 1 treatment                       obvious candidate. The identification TbSPPS was <br /> the depletion UQ pool. The BSF parasites treated                   straightforward high sequence similarity T. cruzi <br /> the inhibitor concentration close EC50, UQ                      homologue. The protein detected PCF BSF cells <br /> extracted separated HPLC. As anticipated, significant                      downregulation RNAi inhibition TbSPPS <br /> reduction UQ9 pool (90%) observed con-                       affected growth of them. <br /> ditions (Fig. 7A), compared extraction standard (UQ10).                           In cells, UQ involved respiration, linked to <br />     UQ mediates transfer electrons that, respi-                  activities. Deficient respiration reflected dimin- <br /> ratory chain and/or glycerol 3- phosphate:dihydroxyacetone-                     ished oxygen consumption, observed PCF <br /> phosphate shuttle, passed oxygen final acceptor. We                   BSF RNAi induction inhibition compound 1. <br /> have shown oxygen consumption cells incubated com-                      Insufficient mitochondrial (and glycosomal) NADH reoxidation <br /> pound 1 Fig. 3. When increased concentrations compound 1                      reflected lowered total ATP altered generation of <br /> were used, respiration drop 13% BSF                       &#226;&#338;&#172;&#226;&#338;&#191;m. The effect addition glycerol RNAi-induced <br /> and 16% PCF, compared non-treated cells. As                       BSF highlighted survival mechanism cells experiencing an <br /> targeting TbSPPS RNAi, switch KCN-sensi-                       imbalance NADH/NAD&#226;&#171;&#185; ratio glycosomes. In fact, the <br /> tive SHAM-sensitive respiration inhibited parasites (see                  failure efficiently reoxidate NADH glycerol-3- <br /> Fig. S3). Trypanosomes reoxidize NADH pool res-                       phosphate:dihydroxyacetone-phosphate shuttle bolstered the <br /> piration. After inhibition compound 1, reduced rate                       production glycerol action glycerol-3-phosphate <br /> reoxidation insufficient provide ATP gly-                     dehydrogenase glycerol kinase. Hence, hindering out- <br /> colysis. We measured ATP pool BSF using lumines-                      let exogenous glycerol seriously affected cell growth. <br /> cent assay. The results expressed luminescent arbitrary                         Nitrogen-containing bisphosphonates earlier be <br /> units (lau) 5 &#226;&#171;&#187; 104 BSF cells. In comparison untreated                     effective vitro vivo T. cruzi toxicity the <br /> cells (1.4 &#226;&#171;&#187; 105 &#226;&#171;&#190; 28000 lau), treatment 2 &#226;?&#174;M compound 1                       host cells (47). <span id='am-3' about='protege:FROM' typeof='owl:Thing'>From</span> experiment compound 1 RNAi- <br /> lowered signal 6.75 &#226;&#171;&#187; 104 lau, represents 51%                        induced T. brucei, concluded TbSPPS inhibited in <br /> decrease.                                                                           fashion TcSPPS, reflection high similarities of <br />     We tested &#226;&#338;&#172;&#226;&#338;&#191;m variation. Low concentrations                         respective active sites. In fact, compound 1 effi- <br /> compound 1 produced mild increase potential, con-                    cient RNAi abolishing enzymatic activity TbSPPS, <br /> centrations exceeding respective EC50 caused slight de-                     leading lethal phenotype. Regarding redox balance, mas- <br /> crease life stages, significant (10 &#226;&#8364;&#8220;20%) PCF                 sive buildup ROS detected PCF following RNAi induc- <br /> (Fig. 7B). Dissipation 80% potential addition               tion, similar lesser effect seen treatment <br /> uncoupler CCCP served negative control. As respiratory chain                   compound 1. An incremented production ROS the <br /> is major source ROS (46), alterations expected               respiratory chain controlled mechanisms involving <br /> generate ROS. When compared single peak                        iron superoxide dismutases, transform superoxide radicals <br /> untreated cells, PCF incubated compound 1 formed popu-                       oxygen hydrogen peroxide. As isoforms of <br /> lation 25&#226;&#8364;&#8220;35% higher ROS, additional                          enzymes distributed glycosomes, cytosol, mitochon- <br /> population fluorescent particles (Fig. 7C). The BSF cells,                dria (48, 49), address are <br /> which lack functional respiratory chain, depleted                      overexpressed TbSPPS knockdowns. In conclusion, in <br /> TbSPPS treated compound 1 generate normal                           RNAi knockdown parasites treated with <br /> amount ROS. However, similarly PCF, higher concentra-                         compound 1, generation maintenance &#226;&#338;&#172;&#226;&#338;&#191;m <br /> tions inhibitor generated second peak lower ROS                     ROS main cause phenotype triggered tam- <br /> concentration, likely representing dead dying cells.                             pering TbSPPS. <br />     Next, tested UQ10 rescue growth inhi-                          Without active synthesis isoprenyl chain, UQ pool, <br />  <br />  <br /> February 2014 Volume 13 Number 2                                                                                                               ec.asm.org 325 <br />  Lai et al. <br />  <br />  <br />  <br />                     estimated 0.1 nmol UQ 109 BSF cells (17), dimin- <br />                     ish according half-life which, however, remains undeter- <br />                     mined T. brucei. The UQ half-life varies different organisms, <br />                     ranging rat tissues 49 125 h (50), human <br />                     blood 34 h (51). The HPLC results BSF inhibi- <br />                     tion 3 days confirmed huge exhaustion pool, suggest- <br />                     ing half-life T. brucei UQ comparable other <br />                     organisms. The HPLC experiment provided additional data <br />                     UQ9 content T. brucei cells. The average value ob- <br />                     tained 1.825 ng/106 cells, equivalent 2.3 nmol/109 cells. This <br />                     represents 1.3 million molecules cell, value higher the <br />                     reported (17) lower described cells. <br />                     For example, hepatocytes, cells 50 times larger volume, <br />                     contain 246 million molecules cell (52). <br />                         Amino-bisphosphonates caused ATP decrease tape- <br />                     worm model (53), molecular mechanism been <br />                     described. In T. brucei, ATP generation probably affected <br />                     directly decrease TbSPPS. PCF cells obtain bulk of <br />                     ATP substrate-level phosphorylation (54, 55) oxidative <br />                     phosphorylation (35). Through depletion NAD&#226;&#171;&#185;, however, <br />                     interference indirectly affect ATP-producing pro- <br />                     cesses. The likely happen BSF, metabolize <br />                     glucose glycosomes (56) depend NADH reoxidation in <br />                     mitochondria UQ-dependent glycerol-3-phosphate <br />                     shuttle. Thus, significant decrease ATP plausibly caused the <br />                     growth phenotype and, longer times higher concentrations <br />                     compound 1, lethal outcome. <br />                         Another factor considered acquisition UQ from <br />                     serum, replenish dwindling intracellular pool, <br />                     following RNAi-mediated ablation TbSPPS inhibition <br />                     drug. In organisms including humans, UQ defi- <br />                     ciency increases uptake transport exogenous UQ to <br />                     mitochondria (57, 58). In serum, UQ normally transported <br />                     lipid particles, (very) low- high-density lipo- <br />                     proteins, taken specific cell receptors, of <br />                     described T. brucei (59&#226;&#8364;&#8220;61). It also <br />                     demonstrated parasite&#226;&#8364;&#8482;s growth affected lipoprotein- <br />                     free serum presence antireceptor antibodies (59, 62). <br />                         Alone complex &#226;?&#164;-cyclodextrin, UQ10 appar- <br />                     ently taken trypanosomes, exogenous UQ rescued <br />                     growth, affected RNAi-mediated down- <br />                     regulation specific inhibition TbSPPS. The complementa- <br />                     tion effect exogenous UQ inhibited parasites clearly pin- <br />                     points UQ biosynthesis protein farnesylation the <br />                     main target compound 1. While highlighting importance of <br />  <br />  <br />  <br />                     FIG 7 Metabolic effects inhibition compound 1 wild-type para- <br />                     sites. (A) Measurement UQ pool. HPLC representative runs un- <br />                     treated treated bloodstreams shown. The positions calibration <br />                     standards indicated arrows. (B) The &#226;&#338;&#172;&#226;&#338;&#191;m displayed procyclics <br />                     treated different concentrations compound 1. Statistical analysis <br />                     results representative experiment presented. Asterisks indicate <br />                     significant differences comparison control group (untreated par- <br />                     asites). The arrowhead represents position depolarized mem- <br />                     brane control, CCCP. (C) ROS level procyclics treated 72 h 50 <br />                     &#226;?&#174;M compound 1. The data means &#226;&#171;&#190; standard deviations least <br />                     independent experiments. (D) Rescue parental SM bloodstream <br />                     cells. The addition 10 &#226;?&#174;M compound 1 medium lethal within <br />                     3 days (SM &#226;&#171;&#185; Comp1). Further addition 20 &#226;?&#174;M UQ10 fully rescued cell <br />                     growth. Nontreated (SM) cells treated UQ10 (SM &#226;&#171;&#185; UQ10) <br />                     used controls. <br />  <br />  <br />  <br /> 326    ec.asm.org                                                                 Eukaryotic Cell <br />                                                                                                                            T. brucei Solanesyl Diphosphate Synthase <br />  <br />  <br />  <br /> UQ BSF cells, rescue experiments results                      protein farnesyltransferase Trypanosoma brucei. J. Biol. Chem. 275: <br /> accordance earlier report, synvinolin                        21870 &#226;&#8364;&#8220;21876. http://dx.doi.org/10.1074/jbc.M000975200. <br />                                                                                   8.   Garzoni LR, Caldera A, Meirelles M, Castro NSL, Docampo R, <br /> (simvastatin) reduced cell growth inhibition                        Meints GA, Oldfield E, Urbina JA. 2004. Selective vitro effects the <br /> first enzyme mevalonate pathway, 3-hydroxy-3-meth-                          farnesyl pyrophosphate synthase inhibitor risedronate Trypanosoma <br /> ylglutaryl coenzyme A reductase (62). This enzyme responsible                       cruzi. Int. J. Antimicrob. Agents 23:273&#226;&#8364;&#8220;285. http://dx.doi.org/10.1016/j <br /> for synthesis sterols isoprenoids. The addition exog-                    .ijantimicag.2003.07.020. <br /> enous mevalonate low-density lipoprotein particles,                      9.   Szajnman SH, Garc&#195;&#173;a Li&#195;&#177;ares GE, Li ZH, Jiang C, Galizzi M, Bontempi <br />                                                                                        EJ, Ferella M, Moreno SN, Docampo R, Rodriguez JB. 2008. Synthesis <br /> transport final products pathway, com-                       biological evaluation 2-alkylaminoethyl-1,1-bisphosphonic acids <br /> pletely reverted phenotype. Interestingly, growth re-                      Trypanosoma cruzi Toxoplasma gondii targeting farnesyl <br /> verted efficiently exogenous cholesterol alone, indicating                     diphosphate synthase. Bioorg. Med. Chem. 16:3283&#226;&#8364;&#8220;3290. http://dx.doi <br /> that essential product(s) present low-density lipo-                     .org/10.1016/j.bmc.2007.12.010. <br />                                                                                  10.   Demoro B, Caruso F, Rossi M, Ben&#195;&#173;tez D, Gonzalez M, Cerecetto H, <br /> protein particles, UQ, depleted synvinolin in- <br />                                                                                        Paraj&#195;&#179;n-Costa B, Castiglioni J, Galizzi M, Docampo R, Otero L, <br /> hibition (62).                                                                         Gambino D. 2010. Risedronate metal complexes potentially active against <br />     The experiment transfected parasites RNAi in-                        Chagas disease. Inorg. Biochem. 104:1252&#226;&#8364;&#8220;1258. http://dx.doi.org/10 <br /> duced vivo showed interference synthesis                           .1016/j.jinorgbio.2010.08.004. <br /> TbSPPS doubled life span infected mice, confirming                11.   Garzoni LR, Waghabi MC, Baptista MM, Castro SL, Meirelles M de, <br />                                                                                        Britto NCC, Docampo R, Oldfield E, Urbina JA. 2004. Antiparasitic <br /> in vitro results. Furthermore, anticipated, excess glycerol                  activity risedronate murine model acute Chagas&#226;&#8364;&#8482; disease. Int. J. <br /> further substantially prolonged survival infected animals.                      Antimicrob. Agents 23:286 &#226;&#8364;&#8220;290. http://dx.doi.org/10.1016/j.ijantimicag <br /> The experiments reported TbSPPS main                             .2003.07.019. <br /> target compound 1 blocking biosynthesis                  12.   Ferella M, Montalvetti A, Rohloff P, Miranda K, Fang J, Reina S, Kawa- <br /> UQ important metabolic consequences T. brucei life                        mukai M, B&#195;&#186;a J, Nilsson D, Pravia C, Katzin A, Cassera MB, Aslund L, <br />                                                                                        Andersson B, Docampo R, Bontempi EJ. 2006. A solanesyl-diphosphate <br /> stages.                                                                                synthase localizes glycosomes Trypanosoma cruzi. J. Biol. Chem. 281: <br />                                                                                        39339 &#226;&#8364;&#8220;39348. http://dx.doi.org/10.1074/jbc.M607451200. <br /> ACKNOWLEDGMENTS                                                                  13.   Besteiro S, Barrett MP, Rivi&#195;&#168;re L, Bringaud F. 2005. Energy generation <br />                                                                                        insect stages Trypanosoma brucei: metabolism flux. Trends Para- <br /> We thank Andrej &#197;&#160;midovnik (National Institute Chemistry, Ljubljana,                 sitol. 21:185&#226;&#8364;&#8220;191. http://dx.doi.org/10.1016/j.pt.2005.02.008. <br /> Slovenia) provision UQ10/&#226;?&#164;-cyclodextrin complex, Claudia          14.   Tielens AGM, van Hellemond JJ. 2009. Surprising variety energy <br /> Nose (Instituto Nacional Parasitolog&#195;&#173;a, Buenos Aires, Argentina)                metabolism Trypanosomatidae. Trends Parasitol. 25:482&#226;&#8364;&#8220; 490. <br /> art work, Philippe Bastin (Institut Pasteur, Paris, France) comments               http://dx.doi.org/10.1016/j.pt.2009.07.007. <br /> on manuscript, Marcelo Arg&#195;&#188;elles (Universidad Nacional                15.   Ellis JE, Setchell KDR, Kaneshiro ES. 1994. Detection ubiquinone in <br /> Quilmes, Argentina) help flow cytometry experiments. Laurie               parasitic free-living protozoa, including species devoid mitochon- <br /> K. Read (State University New York, Buffalo, NY) kindly provided                    dria. Mol. Biochem. Parasitol. 65:213&#226;&#8364;&#8220;224. <br />                                                                                  16.   Clarkson AB, Bienen EJ, Pollakis G, Grady RW. 1989. Respiration of <br /> antibodies.                                                                            bloodstream forms parasite Trypanosoma brucei brucei dependent <br />     This work supported FOCANLIS2010, FOCAN-                            plant-like alternative oxidase. J. Biol. Chem. 264:17770 &#226;&#8364;&#8220;17776. <br /> LIS2013, Instituto Nacional Parasitolog&#195;&#173;a Dr. Mario Fatala            17.   L&#195;&#182;w P, Dallner G, Mayor S, Cohen S, Chait BT, Menon AK. 1991. The <br /> Chab&#195;&#169;n, A.N.L.I.S. Dr. Carlos G. Malbr&#195;&#161;n E.J.B., Grant Agency                mevalonate pathway bloodstream form Trypanosoma brucei. <br /> the Czech Republic P305/11/2179, project BIOGLOBE CZ.1.07/2.3.00/                      Identification dolichols containing 11 12 isoprene residues. J. Biol. <br /> 30.0032, AMVIS LH12104, Praemium Academiae award J.L.,                      Chem. 266:19250 &#226;&#8364;&#8220;19257. <br /> who Fellow Canadian Institute Advanced Research.            18.   Schnaufer A, Clark-Walker JD, Steinberg AG, Stuart K. 2005. The <br />                                                                                        F1-ATP synthase complex bloodstream stage trypanosomes un- <br />                                                                                        usual essential function. EMBO J. 24:4029 &#226;&#8364;&#8220; 4040. http://dx.doi.org <br /> REFERENCES                                                                             /10.1038/sj.emboj.7600862. <br />  1. Legros D, Ollivier G, Gastellu-Etchegorry M, Paquet C, Burri C, Jannin       19.   Sugioka K, Nakano M, Totsune-Nakano H, Minakami H, Tero-Kubota <br />     J, B&#195;&#188;scher P. 2002. Treatment human African trypanosomiasis: present            S, Ikegami Y. 1988. Mechanism O2&#226;&#171;&#186; generation reduction and <br />     situation needs research development. Lancet Infect. Dis.              oxidation cycle ubiquinones model mitochondrial electron <br />     2:437&#226;&#8364;&#8220; 440. http://dx.doi.org/10.1016/S1473-3099(02)00321-3.                       transport systems. Biochim. Biophys. Acta 936:377&#226;&#8364;&#8220;385. <br />  2. Ohnuma S, Hirooka K, Tsuruoka N, Yano M, Ohto C, Nakane H,                   20.   Turrens JF, Boveris A. 1980. Generation superoxide anion the <br />     Nishino T. 1998. A pathway polyprenyl diphosphate elongates               NADH dehydrogenase bovine heart mitochondria. Biochem. J. 191: <br />     prenyltransferase. Insight common mechanism chain length de-             421&#226;&#8364;&#8220; 427. <br />     termination prenyltransferases. J. Biol. Chem. 273:26705&#226;&#8364;&#8220;26713.           21.   Morales J, Mogi T, Mineki S, Takashima E, Mineki R, Hirawake H, <br />  3. Yokoyama K, Lin Y, Stuart KD, Gelb MH. 1997. Prenylation proteins               Sakamoto K, Omura S, Kita K. 2009. Novel mitochondrial complex II <br />     Trypanosoma brucei. Mol. Biochem. Parasitol. 87:61&#226;&#8364;&#8220; 69.                         isolated Trypanosoma cruzi composed 12 peptides including a <br />  4. Field H, Blench I, Croft S, Field MC. 1996. Characterisation protein            heterodimeric Ip subunit. J. Biol. Chem. 284:7255&#226;&#8364;&#8220;7263. http://dx.doi.org <br />     isoprenylation procyclic form Trypanosoma brucei. Mol. Biochem.                 /10.1074/jbc.M806623200. <br />     Parasitol. 82:67&#226;&#8364;&#8220; 80.                                                        22.   Fang J, Beattie DS. 2002. Rotenone-insensitive NADH dehydrogenase is <br />  5. Montalvetti A, Fernandez A, Sanders JM, Ghosh S, Van Brussel E,                    potential source superoxide procyclic Trypanosoma brucei mito- <br />     Oldfield E, Docampo R. 2003. Farnesyl pyrophosphate synthase                 chondria. Mol. Biochem. Parasitol. 123:135&#226;&#8364;&#8220;142. http://dx.doi.org/.10.10 <br />     essential enzyme Trypanosoma brucei. In vitro RNA interference           16/S0166-685(02)00139-1. <br />     vivo inhibition studies. J. Biol. Chem. 278:17075&#226;&#8364;&#8220;17083. http://dx.doi.org   23.   Panigrahi AK, Z&#195;&#173;kov&#195;&#161; A, Dalley RA, Acestor N, Ogata Y, Anupama A, Myler <br />     /10.1074/jbc.M210467200.                                                           PJ, Stuart KD. 2008. Mitochondrial complexes Trypanosoma brucei: novel <br />  6. Yokoyama K, Trobridge P, Buckner FS, Van Voorhis WC, Stuart KD,                    complex unique oxidoreductase complex. Mol. Cell. Proteomics <br />     Gelb MH. 1998. Protein farnesyltransferase Trypanosoma brucei: A              7:534 &#226;&#8364;&#8220;545. http://dx.doi.org/10.1074/mco.M700430-MCP200. <br />     heterodimer 61- 65-kDa subunits new target antiparasite      24.   Opperdoes FR, Michels PA. 2008. Complex I Trypanosomatidae: does <br />     therapeutics. J. Biol. Chem. 273:26497&#226;&#8364;&#8220;26505.                                      exist? Trends Parasitol. 24:310 &#226;&#8364;&#8220;317. http://dx.doi.org/10.1016/j.pt.2008 <br />  7. Buckner FS, Yokoyama K, Nguyen L, Grewal A, Erdjument-Bromage                      .03.013. <br />     H, Tempst P, Strickland CL, Xiao L, Van Voorhis WC, Gelb MH. 2000.           25.   Verner Z, C&#203;&#8225;erm&#195;&#161;kov&#195;&#161; P, &#197;&#160;kodov&#195;&#161; I, Kriegov&#195;&#161; E, Horv&#195;&#161;th A, Luke&#197;&#161; J. <br />     Cloning, heterologous expression, distinct substrate specificity            2011. Complex I (NADH:ubiquinone oxidoreductase) active but <br />  <br />  <br />  <br /> February 2014 Volume 13 Number 2                                                                                                                  ec.asm.org 327 <br />  Lai et al. <br />  <br />  <br />  <br />       non-essential procyclic Trypanosoma brucei. Mol. Biochem. Parasitol.               clinical practical applications. Sports Med. 26:145&#226;&#8364;&#8220;167. http://dx <br />       175:196 &#226;&#8364;&#8220;200. http://dx.doi.org/10.1016/j.molbiopara.2010.11.003.                      .doi.org/10.2165/00007256-199826030-00002. <br /> 26.   Surve S, Heestand M, Panicucci B, Schnaufer A, Parsons M. 2012.                  45.   Yabu Y, Minagawa N, Kita K, Nagai K, Honma M, Sakajo S, Koide T, <br />       Enigmatic presence mitochondrial complex I Trypanosoma brucei                    Ohta N, Yoshimoto A. 1998. Oral intraperitoneal treatment of <br />       bloodstream forms. Eukaryot. Cell 11:183&#226;&#8364;&#8220;193. http://dx.doi.org/10.1128                Trypanosoma brucei brucei combination ascofuranone glyc- <br />       /EC.05282-11.                                                                          erol mice. Parasitol. Int. 47:131&#226;&#8364;&#8220;137. <br /> 27.   Santos-Oca&#195;&#177;a C, C&#195;&#179;rdoba F, Crane FL, Clarke CF, Navas P. 1998.                   46.   Boveris A, Oshino N, Chance B. 1972. The cellular production hydro- <br />       Coenzyme Q6 iron reduction responsible extracellular                   gen peroxide. Biochem. J. 128:617&#226;&#8364;&#8220; 630. <br />       ascorbate stabilization plasma membrane Saccharomyces cerevi-          47.   Urbina JA, Moreno B, Vierkotter S, Oldfield E, Payares G, Sanoja C, <br />       siae. J. Biol. Chem. 273:8099 &#226;&#8364;&#8220; 8105.                                                  Bailey BN, Yan W, Scott DA, Moreno SN, Docampo R. 1999. Trypano- <br /> 28.   Lai D-H, Bontempi EJ, Luke&#197;&#161; J. 2012. Trypanosoma brucei solanesyl-                     soma cruzi contains major pyrophosphate stores, growth vitro <br />       diphosphate synthase localizes mitochondrion. Mol. Biochem.                     vivo blocked pyrophosphate analogs. J. Biol. Chem. 274: <br />       Parasitol. 183:189 &#226;&#8364;&#8220;192. http://dx.doi.org/10.1016/j.molbiopara.2012.02                33609 &#226;&#8364;&#8220;33615. <br />       .011.                                                                            48.   Dufernez F, Yernaux C, Gerbod D, No&#195;&#171;l C, Chauvenet M, Wintjens R, <br /> 29.   Chou TC. 2006. Theoretical basis, experimental design, computer-                   Edgcomb VP, Capron M, Opperdoes FR, Viscogliosi E. 2006. The <br />       ized simulation synergism antagonism drug combination stud-                  presence iron-containing superoxide dismutase isozymes in <br />       ies. Pharmacol. Rev. 58:621&#226;&#8364;&#8220; 681. http://dx.doi.org/10.1124/pr.58.3.10.                trypanosomatidae: characterization, subcellular localization, phylo- <br /> 30.   Wang Z, Morris JC, Drew ME, Englund PT. 2000. Inhibition                            genetic origin Trypanosoma brucei. Free Radic. Biol. Med. 40:210 &#226;&#8364;&#8220;225. <br />       Trypanosoma brucei gene expression RNA interference using inte-                  http://dx.doi.org/10.1016/j.freeradbiomed.2005.06.021. <br />       gratable vector opposing T7 promoters. J. Biol. Chem. 275:40174 &#226;&#8364;&#8220;           49.   Wilkinson SR, Prathalingam SR, Taylor MC, Ahmed A, Horn <br /> </body></html>